RECENT COMMENTS

Tatiana: What about severe neutropenia (grade4) without fever, is it an indication for filgrastim   »Read more

antonio: What about febrile neutropenia in children? is antibiotic prophilaxys recommended? There is not any [...]   »Read more

Baffour Awuah (Male breast cancer): This is a wonderful and provocative subject.Male breast cancers are real issues that has been swept [...]   »Read more

Phil Stewart (Male breast cancer): As a recently diagnosed male breast cancer patinet,it is encouraging to see these groups are promoti [...]   »Read more

Anatolian Society of Medical Oncology (political oncology): Dear editor We read the article on political oncology with deep regret and disappointment. Regret b [...]   »Read more

Masterpiece

Sorry, this page is currently under construction, however you can find the article you are looking for in the Previous Issues section

Issue 33
The power behind the World Cancer Declaration 
Issue 32
Vested interests are undermining our efforts to beat cancer: the worries of a battle-hardened German oncologist 
Issue 31
Surfing the wave
Issue 30
Closing the gap with the West
Issue 29
New drug combinations are not the solution
Issue 28
Siding with the vulnerable
Issue 27
A reverence for life in turbulent times
Issue 26
Balancing cure and care One surgeon’s multidisciplinary quest to raise standards across the board
Issue 25
A scientist without borders
Issue 24
The people's pharmacologist
Issue 23
Scientific integrity must always come first 
Issue 22
A very useful doctor
Issue 21
The passion behind big cancer projects
Issue 20
The birth of the breast unit: a Florentine tale 
Issue 19
The minimalist of St Mark’s 
Issue 18
Where East meets West 
Issue 17
You need to divorce to become good friends
Issue 16
Tackling cancer the Tunisian way 
Issue 15
Spread the word 
Issue 14
The man behind the margins 
Issue 13
The Moscow smokebuster 
Issue 12
If the cardiologists can do it, so can we 
Issue 11
Mr Hodgkin's disease 
Issue 10
Gynaecological oncology: Hungary has a word for it 
Issue 9
Switzerland's cancer president 
Issue 8
All in the blood 
Issue 7
Finding the viral link: the story of Harald zur Hausen 
Issue 6
Vince De Vita: the view from the top 
Issue 5
Jean-Claude Horiot: the innocent inquisitor 
Issue 4
Sophie Fossa: The survival expert 
Issue 3
Richard Doll: Science will always win in the end 
Issue 2
Louis Denis: Urology's foremost free thinker 
Issue 1
Bob Pinedo: Bringing two worlds together 
Special Issue 2006-2007
Helping Tunisia face cancer 'sans peur' 
Special Issue 2005
Eduardo Cáceres Graziani: la cirugía del cáncer es más que una tecnica;
Bob Pinedo: uniendo dos mundos

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR89 - The role of accelerated partial breast irradiation in the treatment of early-stage breast cancer (in co-operation with OECI)

GR90 - Targeted therapies and radiotherapy in head and neck cancer

GR91 - GEJ and gastric cancers: Treatment overview

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck and Novartis.